GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » Marketable Securities

Kilitch Drugs (India) (BOM:524500) Marketable Securities : ₹496 Mil (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Kilitch Drugs (India)'s Marketable Securities for the quarter that ended in Mar. 2025 was ₹496 Mil.

Kilitch Drugs (India)'s annual Marketable Securities increased from Mar. 2023 (₹393 Mil) to Mar. 2024 (₹501 Mil) but then declined from Mar. 2024 (₹501 Mil) to Mar. 2025 (₹496 Mil).


Kilitch Drugs (India) Marketable Securities Historical Data

The historical data trend for Kilitch Drugs (India)'s Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Marketable Securities Chart

Kilitch Drugs (India) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 364.01 472.34 393.31 501.09 495.97

Kilitch Drugs (India) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 501.09 - 535.39 - 495.97

Kilitch Drugs (India) Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Kilitch Drugs (India)  (BOM:524500) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Kilitch Drugs (India) Marketable Securities Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines